The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery disease

Journal of Vascular Surgery ◽

10.1016/j.jvs.2020.08.129 ◽

2020 ◽

Author(s):

Domenico R. Nastasi ◽

Joseph V. Moxon ◽

Richard Norman ◽

Alexandra F. Trollope ◽

Sophie Rowbotham ◽

...

Keyword(s):

Cost Effectiveness ◽

Peripheral Artery Disease ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Peripheral Artery ◽

Artery Disease ◽

The Cost

Download Full-text

P1635Impact of serum low-density lipoprotein cholesterol level after endovascular therapy for symptomatic peripheral artery disease

European Heart Journal ◽

10.1093/eurheartj/ehy565.p1635 ◽

2018 ◽

Vol 39 (suppl_1) ◽

Author(s):

Y Tomoi ◽

K Yamaji ◽

Y Soga ◽

S Hiramori ◽

K Ando

Keyword(s):

Cholesterol Level ◽

Peripheral Artery Disease ◽

Endovascular Therapy ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Peripheral Artery ◽

Artery Disease

Download Full-text

Impact of different statins on low-density lipoprotein cholesterol levels in patients with peripheral artery disease

Atherosclerosis ◽

10.1016/j.atherosclerosis.2021.06.886 ◽

2021 ◽

Vol 331 ◽

pp. e288

Author(s):

K. Gebauer ◽

N. Malyar

Keyword(s):

Peripheral Artery Disease ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Peripheral Artery ◽

Cholesterol Levels ◽

Artery Disease

Download Full-text

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease

Circulation ◽

10.1161/circulationaha.117.032235 ◽

2018 ◽

Vol 137 (4) ◽

pp. 338-350 ◽

Cited By ~ 253

Author(s):

Marc P. Bonaca ◽

Patrice Nault ◽

Robert P. Giugliano ◽

Anthony C. Keech ◽

Armando Lira Pineda ◽

...

Keyword(s):

Peripheral Artery Disease ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Peripheral Artery ◽

Cholesterol Lowering ◽

Artery Disease

Download Full-text

P1405Optimal serum low-density lipoprotein cholesterol management after endovascular therapy for symptomatic peripheral artery disease

European Heart Journal ◽

10.1093/eurheartj/ehx502.p1405 ◽

2017 ◽

Vol 38 (suppl_1) ◽

Author(s):

Y. Tomoi ◽

Y. Soga ◽

S. Hiramori ◽

K. Ando

Keyword(s):

Peripheral Artery Disease ◽

Endovascular Therapy ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Peripheral Artery ◽

Artery Disease ◽

Cholesterol Management

Download Full-text

Faculty Opinions recommendation of Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732115059.793542827 ◽

2018 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Peripheral Artery Disease ◽

Outcomes Research ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Elevated Risk ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Peripheral Artery ◽

Artery Disease ◽

Pcsk9 Inhibition

Download Full-text

Letter by Calabrò et al Regarding Article, “Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)”

Circulation ◽

10.1161/circulationaha.117.033137 ◽

2018 ◽

Vol 138 (2) ◽

pp. 218-219

Author(s):

Paolo Calabrò ◽

Felice Gragnano ◽

Arturo Cesaro

Keyword(s):

Peripheral Artery Disease ◽

Outcomes Research ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Elevated Risk ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Peripheral Artery ◽

Artery Disease ◽

Pcsk9 Inhibition

Download Full-text

Response by Bonaca and Sabatine to Letters Regarding Article, “Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)”

Circulation ◽

10.1161/circulationaha.118.034864 ◽

2018 ◽

Vol 138 (2) ◽

pp. 222-223 ◽

Cited By ~ 1

Author(s):

Marc P. Bonaca ◽

Marc S. Sabatine

Keyword(s):

Peripheral Artery Disease ◽

Outcomes Research ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Elevated Risk ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Peripheral Artery ◽

Artery Disease ◽

Pcsk9 Inhibition

Download Full-text

Letter by Alkhalil Regarding Article, “Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)”

Circulation ◽

10.1161/circulationaha.117.033207 ◽

2018 ◽

Vol 138 (2) ◽

pp. 220-221

Author(s):

Mohammad Alkhalil

Keyword(s):

Peripheral Artery Disease ◽

Outcomes Research ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Elevated Risk ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Peripheral Artery ◽

Artery Disease ◽

Pcsk9 Inhibition

Download Full-text

Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.12512 ◽

2017 ◽

Vol 42 (3) ◽

pp. 292-300 ◽

Cited By ~ 3

Author(s):

Y. J. Jeong ◽

H. Kim ◽

S. J. Baik ◽

T. M. Kim ◽

S. J. Yang ◽

...

Keyword(s):

Cost Effectiveness ◽

Cholesterol Level ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

The Cost

Download Full-text

Target level achievement of low-density lipoprotein cholesterol in patients with peripheral artery disease: Improvement potential despite increased statin use

Atherosclerosis ◽

10.1016/j.atherosclerosis.2021.06.885 ◽

2021 ◽

Vol 331 ◽

pp. e288

Author(s):

K. Gebauer ◽

N. Malyar

Keyword(s):

Peripheral Artery Disease ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Target Level ◽

Low Density Lipoprotein Cholesterol ◽

Peripheral Artery ◽

Improvement Potential ◽

Artery Disease ◽

Statin Use

Download Full-text